CATALYST PHARMACEUTICALS, INC.
Clinical trial NCT05796570 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. primary completion date: 2026-09-01 → 2026-08-19 3. enrollment: 37 → 29 participants 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT05796570 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. primary completion date: 2026-09-01 → 2026-08-19 3. enrollment: 37 → 29 participants 4. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (63%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (24%) **Content type:** Clinical